Akrimax to Launch Suprenza ODT

SUPRENZA (phentermine HCl) 15mg, 30mg orally disintegrating tablets by Akrimax
SUPRENZA (phentermine HCl) 15mg, 30mg orally disintegrating tablets by Akrimax

Akrimax announced their plans to launch Suprenza (phentermine HCl) orally disintegrating tablets (ODT) as a short-term adjunct in the management of exogenous obesity.

Phentermine HCl is a sympathomimetic amine anorectic indicated for patients with an initial body mass index (BMI) of ≥30kg/m2 or ≥27kg/m2 in the presence of other risk factors (eg, controlled hypertension, diabetes, hyperlipidemia).

Suprenza ODT will be available from Akrimax in 15mg and 30mg dosage strengths in 30- and 100-count bottles.

For more information call (888) 383-1733 or visit www.suprenza.com.